Hi, you are logged in as , if you are not , please click here
You are shopping as , if this is not your email, please click here

F47 MBI: Antibody Targeted Therapies (Online)

Info
Location
Contact

Event Information

Antibody
Dates of Event
12th February 2019 – 31st December 2029
Last Booking Date for this Event
31st December 2029

Description

This online course is designed to provide an intensive overview of the antibody therapeutics field, enabling you to:

 

  • Gain a comprehensive understanding of the historical aspects, current research and future direction of the development of antibodies as

therapeutics.

  • Provide an overview on key aspects including antibody structure,function, diversity, antibody fragments and Antibody Drug Conjugates

(ADCs)

  • Gain insights to some of the issues that are required to develop antibodies from the bench to the clinic/market and raises issues with regard to manufacture, intellectual property and regulatory aspects.
  • Effectively engage in cross-disciplinary collaborations with other professionals on how to formulate a strategy to design, develop and apply industry regulations and best practice to ensure quality and success.

 

Flexible Learning

Self-paced learning through a series of interactive audio presentations and animated videos. From the date of enrolment, delegates can access online materials for up to 9 months allowing for flexible study.

https://www.ucl.ac.uk/biochemical-engineering/study/mbi-modular-training/mbi-courses/antibody-targeted-therapy

https://www.ucl.ac.uk/biochemical-engineering/study/mbi-modular-training/mbi-courses/antibody-targeted-therapy

Attendee CategoryCost   
Academic Discount.£760.00[Read More]
Standard.£950.00[Read More]

How would you rate your experience today?

How can we contact you?

What could we do better?

   Change Code